This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2002 Remove Drug Development Remove Life Science Related Topics
Patient Experience healthcare technology Health Information HIPAA Health Data Telemedicine Digital Health Healthcare IT Pharmaceuticals Health IT More Related Topics >
article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

NOVEMBER 14, 2022

Mountain Group Partners is an investor dedicated to investing in and actively guiding transformational businesses in the Technology, Animal Health, and Life Sciences sectors. Founded in 2002, MGP has invested in more than 50 companies in these sectors. About Mountain Group Partners. For more information, visit www.mtngp.com.

Life Science 95
Life Science HIPAA Drug Development healthcare technology 95
article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

DECEMBER 11, 2023

It may be a good while before we reach pre-cognitive techniques to ward off disease and accidents, but virtual reality is forging radical recalibrations of everything from drug discovery to bedside care in both the home and the hospital setting. Some of the recent deals underscore the importance of virtual care in the pharmaceutical industry.’

Pharmaceuticals 64
Pharmaceuticals Digital Health Drug Development Life Science 64
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 82,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024